BioSpace News Archive

Best Buy presented St. Jude Children’s Research Hospital® with a gift of $20.8 million as a result of the organization’s record-breaking fundraising year for the St. Jude Thanks and Giving® campaign.

People who report an elevated number of depression symptoms may be more likely to have a stroke years later than people with no depression symptoms or a low number of depression symptoms, according to a preliminary study released that will be presented at the American Academy of Neurology’s 71st Annual Meeting in Philadelphia, May 4 to 10, 2019.

Bristol-Myers Squibb Company will take part in a fireside chat at the Barclays 2019 Global Healthcare Conference on Wednesday, March 13, 2019, in Miami.

Gilead Sciences, Inc. announced 48-week results from a Phase 2/3 study evaluating the efficacy and safety of Biktarvy®, a once-daily single tablet regimen, in virologically suppressed adolescents and children at least 6 years of age who are living with HIV.

Epizyme, Inc., a late-stage company developing novel epigenetic therapies, announced that it intends to offer and sell shares of its common stock and Series A convertible preferred stock in two concurrent but separate underwritten public offerings.

Magenta Therapeutics, a clinical-stage biotechnology company developing novel medicines to bring the curative power of stem cell transplant to more patients, announced that the Company is scheduled to present at the following investor conferences:

Combined company will strengthen and enhance community engagement technology for the senior living industry

The FDA has accepted for review the Company’s MRTPA for VLNTM cigarettes

In the news release, Natera, Inc. Announces Fourth Quarter and Fiscal 2018 Earnings Conference Call, issued 05-Mar-2019 by Natera, Inc.

Sound Pharmaceuticals is pleased to announce the completion of study enrollment in its Phase 2b clinical trial involving Meniere’s Disease.